How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease

Even if amyotrophic lateral sclerosis is still considered an orphan disease to date, its prevalence among the population is growing fast. Despite the efforts made by researchers and pharmaceutical companies, the cryptic information related to the biological and physiological onset mechanisms, as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvez-Llompart, Maria, Zanni, Riccardo, Garcia-Domenech, Ramon, Galvez, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781553/
https://www.ncbi.nlm.nih.gov/pubmed/35056151
http://dx.doi.org/10.3390/ph15010094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781553/
https://www.ncbi.nlm.nih.gov/pubmed/35056151
http://dx.doi.org/10.3390/ph15010094

Ejemplares similares